Newsroom
Companies
Singapore Venture Creation Group 65LAB Awards US$1.69 million to A*STAR-led Project Targeting the Cause of Vision Loss in Glaucoma and NAION
Companies
Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy
Companies
Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical
Companies
Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers
Companies
Rejoni Receives FDA Approval of the Juveena® Hydrogel System to Reduce Intrauterine Adhesions Following Hysteroscopic Adhesiolysis
Companies
Respiree Extends Series A Syndicate with Addition of International Investors to Support Continued Global Growth
Companies
Hummingbird Bioscience Appoints Dr. James Garner as President
Companies
Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer
Companies
Leyden Labs Reports Positive Phase 1 Results for RIG-101, Supporting Advancement into Phase 2 to Protect Asthma Patients
Companies
Paratus Sciences Announces Updates to its Board of Directors
Companies
IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics
Companies
Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financing